The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Hepatitis C Virus Survival: Syringe Specifics

Back to News Homepage

Next

New Hepatitis C Genotype Test Approved by the FDA

Experimental Hepatitis C Drug Not Yet Accepted by FDA

June 24, 2013

Print this page

Before starting clinical evaluations, the FDA demands more safety data on Idenix Pharmaceuticals’ new drug.

Idenix says FDA delays hepatitis C drug trials

By The Associated Press
June 20, 2013

NEW YORK (AP) — Idenix Pharmaceuticals Inc. said Thursday the Food and Drug Administration wants more safety data on its experimental hepatitis C drug IDX20963 before it will allow the company to begin human testing.

Continue reading this entire article:
http://www.businessweek.com/ap/2013-06-20/idenix-says-fda-delays-hepatitis-c-drug-trials

No Comments - be the first!
Share
Share

Previous

Hepatitis C Virus Survival: Syringe Specifics

Back to News Homepage

Next

New Hepatitis C Genotype Test Approved by the FDA

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.